Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(3.72) per share. This is a 16.98 percent decrease over losses of $(3.18) per share from the same period last year.
This Analyst Slashes Price Target On Colgate-Palmolive? Plus Barclays Sees $78 For General Electric
Wells Fargo cut the price target for Colgate-Palmolive Company (NYSE: CL) from $80 to $75. Colgate-Palmolive shares rose 0.8% to trade at $70.84 on Monday.
